1 Min Read
Jan 8 (Reuters) - Nevro Corp:
* NEVRO RECEIVES FDA APPROVAL FOR SENZA II SPINAL CORD STIMULATION SYSTEM DELIVERING HF10 THERAPY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.